🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11395+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11395 recruiting trials

Phase 2RecruitingNCT06271616

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

👨‍⚕️ Mohamed A. Kharfan Dabaja, MD, MBA, Mayo Clinic📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06628310

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

👨‍⚕️ ABBVIE INC., AbbVie📍 49 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06708468

Personalized Training for People With Rare Neuromuscular Disorders

👨‍⚕️ Kristin Ørstavik, MD, PhD, Oslo University Hospital📍 5 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06394830

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

🏥 Vaneltix Pharma, Inc.📍 5 sites📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06663072

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

👨‍⚕️ Chih-Yi (Andy) Liao, MD, University of Chicago📍 1 site📅 Started Dec 2024View details ↗
Phase 3RecruitingNCT06666764

Normobaric Oxygen in AIS Transferred for EVT

🏥 Capital Medical University📍 112 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06557512

Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma

👨‍⚕️ William Chen, MD, University of California, San Francisco📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT07099144

Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension

🏥 Lee's Pharmaceutical Limited📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06836505

Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.

👨‍⚕️ Yizhuo Zhang, Sun Yat-Sen University Cancer Center📍 3 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06874608

Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis

🏥 Meyer Children's Hospital IRCCS📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06635629

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

👨‍⚕️ Lynnette K Nieman, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06948942

Exercise Capacity, Muscle Oxygenation, and Physical Activity Between Patients With Interstitial Lung Disease

👨‍⚕️ Meral BOŞNAK GÜÇLÜ, Prof. Dr., Gazi University📍 1 site📅 Started Dec 2024View details ↗
Phase 3RecruitingNCT06740916

Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients with Aspirin Resistance

🏥 Siriraj Hospital📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT07201025

Imaging Assessments of ARPKD Kidney Disease Progression

👨‍⚕️ Katherine M Dell, MD, The Cleveland Clinic📍 2 sites📅 Started Dec 2024View details ↗
RecruitingNCT06774677

Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management

👨‍⚕️ Lucia Catani, PhD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 3 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06537193

Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment

👨‍⚕️ So Yeon Kim, MD, PhD, Asan Medical Center📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06747858

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

🏥 Arcturus Therapeutics, Inc.📍 11 sites📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT05460507

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

👨‍⚕️ Andrew J Brenner, PhD, The Cancer Therapy and Research Center at UTHSCSA📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06623890

A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

👨‍⚕️ Medical Director, Biogen📍 14 sites📅 Started Dec 2024View details ↗
EARLY_Phase 1RecruitingNCT06718270

a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

👨‍⚕️ Juan Du, Ph D, Shanghai Changzheng Hospital📍 1 site📅 Started Dec 2024View details ↗
← PreviousPage 189 of 570Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →